Payal Nanavati

Counsel | She/Her/Hers

Overview

Payal Nanavati is a counsel who serves as a liaison between the Health Care and Government Contracts groups. Practicing at the crossroads of the two of the most highly regulated industries, Payal understands the highly technical requirements of government contract law and the equally challenging health care statutes and regulations. This understanding enables her to provide clients in these spaces with efficient and effective legal services.

Payal’s practice covers a wide range of investigation, counseling, and litigation matters for companies in the government contracts and health care industries. She advises and advocates for government contractors and health care entities facing government investigations or high stakes litigation, with a particular focus on the False Claims Act, which is a heightened risk for members of both industries. Payal also helps clients conduct internal investigations and strategically navigate regulatory inquiries, civil investigative demands, and subpoenas issued by federal and state agencies. In addition to her investigations practice, Payal regularly litigates high-value disputes between government contractors and the U.S. government under the Contract Disputes Act. Payal also conducts compliance reviews and proposes enhancements of compliance programs for health care entities, contractors, or grant recipients.

Payal is a co-host of Crowell & Moring’s health care podcast, Payers, Providers, and Patients – Oh My!, which covers legal and regulatory issues that affect health care entities’ in-house counsel, executives, and investors.

Payal’s pro bono representations include clients seeking asylum or legal immigration status under the Violence Against Women Act.

Career & Education

    • Columbia Law School, J.D.
      Journal of Gender and Law: staff member
    • University of North Carolina at Chapel Hill, B.S., highest honors
    • Columbia Law School, J.D.
      Journal of Gender and Law: staff member
    • University of North Carolina at Chapel Hill, B.S., highest honors
    • District of Columbia
    • New York
    • North Carolina
    • District of Columbia
    • New York
    • North Carolina

Payal's Insights

Client Alert | 2 min read | 03.27.26

CMS Releases PY 2020 RADV Audit Methods and Instructions: Key Takeaways for Health Plans

On March 20, 2026, the Centers for Medicare and Medicaid Services (CMS) released new guidance outlining the agency’s audit methods and instructions for Medicare Advantage (MA) plans subject to upcoming risk adjustment data validation (RADV) audits for payment year (PY) 2020. In addition to providing necessary context for MA plans selected for auditing, this resource clarifies CMS’s methodological and procedural expectations. While the high-level takeaways are recapped below for convenience, we strongly recommend that MA organizations selected for PY 2020 audits closely review the guidance to understand what may be involved — or required — during the agency’s review....

Representative Matters

  • Representing hospital systems and plans in disclosing potential overpayments pursuant to the HHS OIG Self-Disclosure Protocol.
  • Representing a Medicare Advantage organization in a DOJ investigation regarding risk adjustment practices.
  • Assisting Medicare Advantage organizations in responding to risk adjustment data validation (RADV) audits and appealing unfavorable results.
  • Assessing and strengthening plan risk adjustment processes and procedures in light of historical audit activity, CMS regulatory activity, and government enforcement initiatives.
  • Defending leading health plan in class action litigation and investigations by state/federal regulators concerning compliance with the Mental Health Parity and Addiction Equity Act and state parity laws.
  • Representing health care clients in the development, enhancement, and implementation of compliance programs.
  • Assessing the reasonableness of legal advice concerning Stark Law and Anti-Kickback Statute compliance to help draft an expert report for a False Claims Act litigation.
  • Representing health plan in intervened False Claims Act litigation involving Medicare Advantage marketing payments to third-party marketing organizations.
  • Representing federal government contractor in audit negotiations with DCAA and DCMA, resulting in elimination and reduction of questioned costs.
  •  Representing a federal contractor in the aerospace industry in a qui tam suit.

Payal's Insights

Client Alert | 2 min read | 03.27.26

CMS Releases PY 2020 RADV Audit Methods and Instructions: Key Takeaways for Health Plans

On March 20, 2026, the Centers for Medicare and Medicaid Services (CMS) released new guidance outlining the agency’s audit methods and instructions for Medicare Advantage (MA) plans subject to upcoming risk adjustment data validation (RADV) audits for payment year (PY) 2020. In addition to providing necessary context for MA plans selected for auditing, this resource clarifies CMS’s methodological and procedural expectations. While the high-level takeaways are recapped below for convenience, we strongly recommend that MA organizations selected for PY 2020 audits closely review the guidance to understand what may be involved — or required — during the agency’s review....

Payal's Insights

Client Alert | 2 min read | 03.27.26

CMS Releases PY 2020 RADV Audit Methods and Instructions: Key Takeaways for Health Plans

On March 20, 2026, the Centers for Medicare and Medicaid Services (CMS) released new guidance outlining the agency’s audit methods and instructions for Medicare Advantage (MA) plans subject to upcoming risk adjustment data validation (RADV) audits for payment year (PY) 2020. In addition to providing necessary context for MA plans selected for auditing, this resource clarifies CMS’s methodological and procedural expectations. While the high-level takeaways are recapped below for convenience, we strongly recommend that MA organizations selected for PY 2020 audits closely review the guidance to understand what may be involved — or required — during the agency’s review....